Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$642,798
+$33,654 QoQ
Shares Held
2,531
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#3,443
of 4,664 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Triumph Capital Management holds $8,936,522 across 15 Drug Manufacturers - General names. JNJ ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,038 | $3,643,868 | |
| 2 | PFE |
Pfizer Inc
|
60,207 | $1,449,784 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
20,678 | $1,191,466 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
2,531 | $642,798 | |
| 5 | AMGN |
Amgen Inc
|
1,644 | $595,325 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,687 | $465,815 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,699 | $346,821 | |
| 8 | ABBV |
AbbVie Inc.
|
1,121 | $282,088 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $642,798 | 2,531 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $609,144 | 2,492 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $562,904 | 2,720 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $453,166 | 2,444 | Shares | Sole | 2025-12-23 | |
| 2025-06-30 | $497,965 | 3,260 | Shares | Sole | 2025-12-29 | |
| 2025-03-31 | $425,047 | 2,563 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $343,038 | 2,372 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $363,500 | 2,243 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $528,076 | 3,613 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $460,174 | 2,909 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,006,114 | 6,419 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $887,930 | 5,701 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $390,792 | 2,361 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $654,565 | 4,223 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $375,734 | 2,127 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $318,715 | 1,951 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $343,126 | 1,933 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $340,636 | 1,922 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $391,066 | 2,286 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $259,692 | 1,608 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $235,907 | 1,432 | Shares | Sole | 2021-07-19 | |
| No filing history on record for this holder in this stock. | ||||||